Biostem Technologies
Clinical trials sponsored by Biostem Technologies, explained in plain language.
Regenerative medicine company developing placental tissue-based products.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
Amniotic membrane patch shows promise for stubborn diabetic wounds
Disease control CompletedThis study tests whether adding a special amniotic membrane graft (BR-AM) to standard wound care helps heal diabetic foot ulcers better than standard care alone. About 72 adults with non-infected, non-healing ulcers will be randomly assigned to receive either BR-AM plus standard …
Phase: NA • Sponsor: BioStem Technologies • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New placental patch shows promise for diabetic foot ulcers
Disease control CompletedThis study tested whether adding a special placental membrane (BR-AC) to standard wound care helps heal diabetic foot ulcers faster. 71 adults with diabetes and foot ulcers were randomly assigned to get either standard care alone or standard care plus BR-AC. The main goal was to …
Phase: NA • Sponsor: BioStem Technologies • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC